Sign up to save your podcasts
Or
Share Stop. Test. Rethink: The Thyroxine Turning Point 🔄🧠💊
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Stop. Test. Rethink: The Thyroxine Turning Point 🔄🧠💊
🧠💊 Stop. Test. Rethink.
A compelling new study in JAMA shows that ~26% of adults ≥60 years can safely discontinue levothyroxine, maintaining normal thyroid function—especially those on low doses (≤50 μg/day).
📉 No meaningful decline in quality of life
đź“Š Clear dose-response signal
⚠️ Raises concerns about lifelong overtreatment
The message is elegant:
Not every prescription deserves permanence.
Time to reassess, deprescribe, and individualize—particularly in our older patients.
#Thyroid #Endocrinology #Deprescribing #Geriatrics #PrecisionMedicine
View all episodes
By Dr RR Baliga, MD, MBA
5
66 ratings
🧠💊 Stop. Test. Rethink.
A compelling new study in JAMA shows that ~26% of adults ≥60 years can safely discontinue levothyroxine, maintaining normal thyroid function—especially those on low doses (≤50 μg/day).
📉 No meaningful decline in quality of life
đź“Š Clear dose-response signal
⚠️ Raises concerns about lifelong overtreatment
The message is elegant:
Not every prescription deserves permanence.
Time to reassess, deprescribe, and individualize—particularly in our older patients.
#Thyroid #Endocrinology #Deprescribing #Geriatrics #PrecisionMedicine
More shows like Dr RR Baliga's "Got Knowledge Doc" Podkast
View all
This Week in Cardiology
906 Listeners
The Curbsiders Internal Medicine Podcast
3,374 Listeners
The Mel Robbins Podcast
20,222 Listeners